The year 2017 marks the 50th anniversary for SCS (spinal cord stimulation) therapy which was first used to treat pain in 1967. To celebrate the occasion, NeuroNews spoke to a number of pioneers in the field about how they have seen spinal cord stimulation therapy change and develop over the years and where they hope to see it improve and grow in the future.
However, SCS therapy is still underutilized.
In the NeuroNews article Dr. Simon Thomson (past president of International Neuromodulation Society) says, "Technological improvements in spinal cord stimulation have meant that the sometimes dominant back pain component of chronic neuropathic back and leg pain (also known as Failed Back Surgery Syndrome) can be treated as well as the leg pain component. This has brought many more patients to the treatment. There are still 10 to 20 fold more patients with this condition who could be treated than we currently are referred."
Lone Star NeuroMODULATION
LSN is targeting unmet clinical needs by creating disruptive device platforms that offer promising solutions for lowering costs, realizing higher returns and effectively addressing more therapeutic indications if adopted for medical applications.